| Position | Action |
|---|---|
| Current $172 level with 37% four-day rally | Trim 10-15% of existing PLTR position to lock in gains and reduce concentrated exposure |
| Breakout extends above $185 with sustained volume | Move remaining 85-90% to Hold |
| Any close below $146 (200 SMA) | Exit remainder of position |
| Price pulls back to $155-165 zone | Phased re-entry with reserved fresh capital |
PLTR presents an overwhelming bull case combining explosive momentum (new ATH on accelerating MACD from +2.51 to +4.79), elite fundamental metrics (85% revenue growth, 47% operating margins, 132 Rule of 40 score, $7.8B net cash), and aligned macro tailwinds with Bank of America raising targets and Polymarket drawdown odds collapsing 40-50 percentage points in a single week.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 146.20 | bullish |
| close_50_sma | 132.60 | bullish |
| close_200_sma | 152.28 | bullish |
| macd_histogram | +4.79 | bullish |
| rsi | 72.83 | neutral |
| bollinger_upper_band | 164.89 | neutral |
| atr | 8.96 | neutral |
| vwma | 142.60 | bullish |
Support: 159.97 · 155.92 · 152.28 · 146.2 · 135.04 | Resistance: 172.41 · 164.89 · 163.7
PLTR staged a high-conviction volume-backed breakout, surging from $125.65 (Aug 3) to a new all-time high of $172.01 (Aug 7) on record volume of 175M shares (Aug 4). Price decisively reclaimed the 200-day SMA at $152.28 and sits 13.0% above it, though the 50 SMA remains below the 200 SMA (death cross structure persists). MACD momentum has completed a full reversal from -7.01 (Jun 26) to +7.19 (Aug 7) with histogram expanding at +4.79. RSI climbed from 27.4 (oversold, Jun 25) to 72.83, marking a textbook V-shaped recovery with no bearish divergence yet. Bollinger Bands (middle $135.04, upper $164.89, lower $105.19) show price extended 4.3% above the upper band, while ATR expanded 42% from $6.32 to $8.96, requiring wider stops of $13–18. VWMA spiked from $128.87 (Jul 29) to $142.60, confirming institutional accumulation rather than a thin-float squeeze. The Aug 5–6 pullback (only ~6% high-to-low) was absorbed cleanly above $155.92, and Aug 7's new high on 76M shares represents a textbook continuation signature. Composite verdict: HOLD for existing positions with trailing stop at $155.92 or ATR-based stop at ~$163; WAIT for pullback to $155–164 zone for new entries.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight PLTR after parabolic rally; trim 10-15% and trail with discipline
Underweight rating reflects unfavorable risk/reward at $172 given 75x forward P/E and 37% recent rally, but breakout quality prevents a full exit. The 10-15% trim, volatility-adjusted trailing stop, and realistic $155-165 re-entry zone balance participation with de-risking. Analyst prioritizes disciplined position management over directional top-calling or waiting for idealized entry levels that may never materialize.
When: Breakout extends above $185 with sustained volume
Then: Move remaining core position to Hold rating
Overbought technical readings lack bearish divergence, and momentum indicators are accelerating rather than rolling over
↩ rebuts: “Bear's overbought RSI (72.83) objection ignores lack of divergence and accelerating momentum”
· concedes: Chase-risk is elevated with stock at new all-time highs; A pullback to the $155–$164 zone would offer a better entry point for new capital; Hot CPI print combined with hawkish Fed pivot and multiple compression could reverse the setup; P/E of 147 trailing is objectively high; Leveraged ETFs (PTIR, PLTU) are not recommended and destroy capital via volatility decay
PLTR is a story stock at peak narrative strength with peak crowding, peak extension, and peak multiple—the breakout was a climax top, not institutional conviction.
· concedes: The Mercury Systems partnership is real and defense-tech procurement cycles are years long; KODE OS FedRAMP authorization is an incremental win; PLTR is currently trading at $172 with 24 days left in August making <$120 probability mathematically low in the short term
→ vs conservative: Valuation metrics of 75x forward P/E and 2.29 PEG are not 'decisive' bearish math — PLTR is elite-tier hyper-growth (85% revenue growth) combined with elite-tier profitability (47% operating margins, 55%+ FCF margins), not a normal software company
→ vs conservative: Technical 'textbook climax signature' reading is wrong — breakout came on 175M shares followed by shallow two-day pullback holding 155, then fresh all-time highs on 76M shares; this is tight consolidation on declining volume, not climax distribution pattern
→ vs conservative: RSI at 73 is not a sell signal when no bearish divergence is present, yet conservative plan still recommends fading the move
→ vs conservative: 'Death cross' framing is intellectually dishonest — price action has decisively invalidated that regime; 200 SMA has been reclaimed and averages are about to curl up; calling 37% rally 'fragile' is pattern-recognition bias
→ vs conservative: Insider dilution argument lacks context — SBC is primary mechanism for retaining engineering and sales talent in AI labor market; alternative is talent attrition that would crater growth; comparison should be SBC as percentage of revenue, which is declining
→ vs conservative: $75 million buyback being 'only 0.02% of market cap' is technically true but irrelevant — company deploys cash at 38% ROE with fortress balance sheet; hoarding capital for reinvestment is rational, not a governance red flag
→ vs conservative: Proposal to trim 15-25% and wait for 146-160 re-entry is classic 'have cake and eat it too' trade that almost never works — either trust the breakout or sell the whole position; splitting the difference means watching PLTR rip to 190 while waiting
Market Capitalization
$413.35B
Trailing P/E
147.0x
Forward P/E
74.8x
PEG Ratio
2.29
Price/Book
42.2x
EPS (TTM)
$1.17
Forward EPS
$2.30
Beta
1.563
52-Week High
$207.52
52-Week Low
$106.37
50-Day Moving Avg
$130.49
200-Day Moving Avg
$152.62
Current Price (implied)
~$161
TTM Revenue
$6,156M
2025 Revenue
$4,475M
2025 Revenue Growth
+56.2%
2024 Revenue
$2,866M
2023 Revenue
$2,225M
2022 Revenue
$1,906M
2021 Revenue
$1,906M
2025 Gross Profit
$3,686M
2025 Gross Margin
82.4%
2025 Operating Income
$1,414M
2025 Operating Margin
31.6%
2025 Net Income
$1,625M
2025 Diluted EPS
$0.63
2024 Net Income
$462M
2024 Diluted EPS
$0.19
Q1 2026 Revenue
$1,633M
Q1 2026 YoY Growth
+85%
Q1 2026 Gross Margin
86.8%
Q1 2026 Operating Income
$754M
Q1 2026 Net Income
$871M
Q1 2026 Diluted EPS
$0.34
Q4 2025 Revenue
$1,407M
Q4 2025 YoY Growth
+64%
Q4 2025 Gross Margin
84.6%
Q4 2025 Operating Income
$575M
Q4 2025 Net Income
$609M
Q4 2025 Diluted EPS
$0.24
Q3 2025 Revenue
$1,181M
Q3 2025 YoY Growth
+54%
Q2 2025 Revenue
$1,004M
Q2 2025 YoY Growth
+48%
Q1 2025 Revenue
$884M
Q1 2025 Gross Margin
80.4%
Q1 2025 Operating Income
$176M
Q1 2025 Net Income
$214M
Q1 2025 Diluted EPS
$0.08
Cash & ST Investments
$8,026M
Cash & Equivalents
$2,292M
Short-Term Investments
$5,735M
Total Receivables
$1,406M
Total Current Assets
$9,552M
Total Assets
$10,199M
Total Debt
$212M
Total Liabilities
$1,643M
Net Cash
~$7.8B
Stockholders' Equity
$8,450M
Current Ratio
7.23x
Working Capital
$8,169M
Book Value per Share
$4.07
Debt/Equity (financial)
0.025
2025 Operating CF
$2,134M
2025 CapEx
$34M
2025 Free Cash Flow
$2,101M
2025 FCF Margin
46.9%
TTM Free Cash Flow
$2,159M
TTM FCF Margin
~35%
Q1 2026 Operating CF
$899M
Q1 2026 FCF
$892M
Q4 2025 Operating CF
$777M
Q4 2025 FCF
$764M
Q3 2025 Operating CF
$508M
Q3 2025 FCF
$501M
Q2 2025 Operating CF
$539M
Q2 2025 FCF
$532M
Q1 2025 Operating CF
$310M
Q1 2025 FCF
$304M
2024 Operating CF
$1,154M
2024 FCF
$1,141M
2024 FCF Margin
39.8%
2023 Operating CF
$712M
2023 FCF
$697M
2023 FCF Margin
31.3%
2022 Operating CF
$224M
2022 CapEx
$40M
2022 FCF
$184M
2022 FCF Margin
9.6%
2025 Buyback
$75M
2025 SBC
$684M
Q1 2026 SBC
$202M
Diluted Share Count Q1 2026
2.57B
Diluted Share Count Q1 2025
2.34B
Annual Dilution Rate
~10%
Profit Margin
49.0%
Operating Margin
47.1%
Gross Margin
84.8%
Return on Equity
38.1%
Return on Assets
17.3%
Rule of 40 (2025)
88
Q1 2026 R&D
$161M
Q1 2026 S&M
$319M
Q1 2026 G&A
$183M
Q1 2026 R&D % Revenue
~10%
Q1 2026 S&M % Revenue
~20%
Strengths
Concerns
Palantir reported exceptional Q1 2026 results with revenue of $1,633M (+85% YoY) and FCF of $892M (55% margin), with full-year 2025 revenue of $4,475M up 56% and net income of $1,625M representing 252% YoY growth. The balance sheet remains fortress-like with $7.8B net cash, while profitability metrics are best-in-class with 49% net margin, 84.8% gross margin, and 38.1% ROE. The primary risks are extreme valuation (147x trailing P/E), ongoing ~10% annual share dilution from stock-based compensation, and customer concentration in government contracts.